Laboratory Alert: Discontinue use of the A549/MV1LU Mix for respiratory viral culture panels and review updated biosafety FAQs

Because of the risk of infection with SARS-CoV-2 among laboratory workers, CDC recommends that laboratories discontinue the use of the A549/MV1LU mix when they perform respiratory viral culture panels. Using these specific cell lines has been shown to result in a very low level of SARS-CoV replication. CDC recommends that laboratories perform respiratory viral culture…

Read more

FDA offers strategies for conservation of PPE

The U.S. Food and Drug Administration (FDA) has released a letter addressing conservation strategies for use by health care organizations and personnel for personal protective equipment (PPE), such as medical gloves; the strategies are categorized for a range of needs and supply levels and are intended to assist health care organizations as they determine procedures…

Read more

FDA Update: Policy for Diagnostic Tests for COVID-19 during the public health emergency

On March 16, 2020, the FDA published notice for “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.” This document supersedes “Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing under Clinical Laboratory Improvement Amendments (CLIA) prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency” issued…

Read more